Severe flare of pemphigus vulgaris after first dose of COVID-19 vaccine

Ong, Samantha K.; Darji, Kavita; Chaudhry, Sofia

doi:10.1016/j.jdcr.2022.01.027

Cited by 10 publications

(12 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[109][110][111][112][113][114][115][116][117][118][119] The largest study on 77 patients developing alopecia areata (39) or a worsening of the disease (38) has been reported by Nguyen et al Unfortunately, it is not possible to correlate alopecia areata development and the type of vaccine. 120 Regarding bullous disorders, a total of 26 cased of pemphigus vulgaris have been reported following COVID-19 vaccination, [121][122][123][124][125][126][127][128][129][130][131][132][133][134][135] with several implications in treatment and management. 136 Moreover, 40 cases of pemphigoids have been described.…”

Section: Resultsmentioning

confidence: 99%

“… BNT162b2: 71 mRNA-1273: 12 AZD1222: 15 Ad26.COV2: 0 Alopecia areata 24 Scollan et al 109 (9), Babadjouni et al 110 (3), Rossi et al 111 (3), Chen et al 112 (2), Abdalla et al 113 (1), Gamonal et al 114 (1), Ho et al 115 (1), Su et al 116 (1), Gallo et al 117 (1), May Lee et al 118 (1), Essam et al 119 (1). BNT162b2: 14 mRNA-1273: 4 AZD1222: 6 Ad26.COV2: 0 Pemphigus vulgaris 26 Martora et al 121 (7), Zou et al 122 (3), Gui et al 123 (2), Rouatbi et al 124 (2), Aryanian et al 125 (1), Koutlas et al 126 (1), Knechtl et al 127 (1), Ong et al 128 (1), Yıldırıcı et al 129 (1), Singh et al 130 (1), Norimatsu et al 131 (1), Agharbi et al 132 (1), Almasi-Nasrabadi et al 133 (1), Corrá et al 134 (1), Solimani et al 135 (1). BNT162b2: 15 mRNA-1273: 6 AZD1222: 5 Ad26.COV2: 0 Pemphigoids 40 Maronese et al 137 (21), Maronese et al 138 (3), Hali et al 139 (3), Gambichler et al 140 (2), Shanshal et al 141 (1), Desai et al 142 (1), Fu et al 143 (1), Alshammari et al 144 (1), Hung et al 145 (1), Pauluzzi et al 146 (1), Dell’Antonia...…”

Section: Methodsmentioning

confidence: 99%

“…Merhy et al62 (1), Camela et al63 (1), Kato et al69 (1), Diab et al70 (1), Zagaria et al71 (1), Awada et al72 (1), Picone et al73 (1), Hlaca et al74 (1), Zengarini et al75 (1), Masseran et al76 (1), Gamonal et al64 (1), Alrawashdeh et al65 (1), Shakoei et al66 (1). Zou et al122 (3), Gui et al123 (2), Rouatbi et al124 (2), Aryanian et al125 (1), Koutlas et al126 (1), Knechtl et al127 (1), Ong et al128 (1), Yıldırıcı et al129 (1), Singh et al130 (1), Norimatsu et al131 (1), Agharbi et al132 (1), Almasi-Nasrabadi et al133 (1),…”

mentioning

confidence: 99%

See 2 more Smart Citations

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

Battista¹,

Marasca²,

Genco³

et al. 2022

CCID

View full text Add to dashboard Cite

The outbreak of coronavirus disease 2019 represented a new worldwide challenge, strongly impacting on the global economy, overall health and lifestyle. Since then, several strategies have been adopted to contain the widespread of infection. Among these, vaccination is currently the most important measure to fight against the pandemic. However, several concerns such as slower-than-hoped-for rollout, the hurried approval with limited data, the mechanism of action (in particular mRNA-based), and the uncertain duration of protection they afforded were initially raised. Moreover, even if cutaneous reactions have been rarely reported in clinical trials, global mass vaccination showed several dermatologic reactions not initially recognized, leaving dermatologists to decide how to diagnose and treat them. In this scenario, dermatologists should be ready to promptly recognize these clinical manifestations. Thus, the aim of this manuscript is to review current literature on cutaneous reactions following COVID-19 vaccination, particularly inflammatory dermatological diseases, in order to help clinicians to better understand these dermatological conditions and to provide an extensive overview of all the vaccine-related skin manifestations.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

Battista¹,

Marasca²,

Genco³

et al. 2022

CCID

View full text Add to dashboard Cite

show abstract

“…Las vacunas pueden generar efectos adversos dermatológicos de novo o exacerbar dermatosis previas 4,5 .…”

Section: Discussionunclassified

“…Dentro de las vacunas, hay publicadas asociaciones con las vacunas contra la influenza, la hepatitis B, la rabia y el tétanos. Recientemente se han publicado casos de PV gatillados o exacerbados por la vacunación contra la COVID-19 3,4 Se presenta el caso de un paciente con PV probablemente gatillado por la vacunación contra la COVID-19 diagnosticado en el Hospital F. J. Muñiz.…”

Section: Introductionunclassified

Reporte de un caso de pénfigo vulgar gatillado por vacunación contra la COV ID-19 y revisión de la literatura

Ginzburg¹,

Forero²,

Candiz³

et al. 2023

MCUT

View full text Add to dashboard Cite

Pemphigus vulgaris is an autoimmune mucocutaneous blistering disease that may be trigger by different factors, such as drugs or vaccines. There are few cases recently published on the association between pemphigus vulgaris and vaccination against COVID-19. We report a case of pemphigus vulgaris probably triggered by vaccination against COVID-19 and a review of the cases reported in medical publications with this relationship is perform.

show abstract

A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID‐19 vaccination: The good, the bad, and the ugly

Najary,

Vatankhah,

Khadivi

et al. 2024

Health Science Reports

View full text Add to dashboard Cite

Background and AimsAnti‐severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccines have the potential to alter several biological systems concurrently with remolding the immune system, most of which are related to immunization, while some others are known as adverse effects. This review aims to explore the potential effects of vaccination on the oral microenvironment and classifies them as good, bad, or ugly, with a brief review of facial diseases following coronavirus disease 2019 (COVID‐19) vaccination.MethodsThis study was a comprehensive review conducted through searching related articles in Medline, Scopus, and Google Scholar databases.ResultsOn one side, the “Good” impacts of vaccination on the oro‐nasal mucosa are explained as if the mucosal immune responses followed by SARS‐CoV‐2 vaccines are enough to provide immunity. On the other side, the possible “Bad” and “Ugly” effects of the vaccine, which manifest as orofacial adverse events and autoimmune reactivations, respectively, should be noted. Exacerbation of pre‐existing autoimmune conditions such as lichen planus, pemphigus vulgaris, bullous pemphigoid, and Stevens‐Johnson syndrome have been reported.ConclusionCOVID‐19 vaccines could affect different biological systems alongside stimulating the immune system, and some of these effects are referred to as adverse effects. Nonetheless, these adverse effects are treatable, and healthcare professionals should not prevent patients from taking the first available vaccination.

show abstract

Severe flare of pemphigus vulgaris after first dose of COVID-19 vaccine

Cited by 10 publications

References 5 publications

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

Reporte de un caso de pénfigo vulgar gatillado por vacunación contra la COV ID-19 y revisión de la literatura

A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID‐19 vaccination: The good, the bad, and the ugly

Contact Info

Product

Resources

About